These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Critical cerebral blood flow thresholds studied by SPECT using xenon-133 and iodine-123 iodoamphetamine. Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K J Nucl Med; 1989 Mar; 30(3):337-42. PubMed ID: 2786938 [TBL] [Abstract][Full Text] [Related]
6. [Assessment of regional cerebral blood flow (rCBF) in cerebrovascular disease using SPECT and N-isopropyl-p-[123I] iodoamphetamine (IMP): comparison with IMP hemispheric uptake count and mean CBF by 133Xe arterial infusion method]. Seto H; Futatsuya R; Kamei T; Taki K; Kakishita M; Moto A; Endo T Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1135-41. PubMed ID: 3879348 [No Abstract] [Full Text] [Related]
7. [Clinical evaluation of cerebral perfusion imaging with 123I-IMP in the patients with cerebrovascular disease--a comparison with 133Xe and X-CT]. Hoshi H; Jinnouchi S; Watanabe K; Nagamachi S; Mizoguchi N; Ozawa M; Ono S; Kinoshita K; Ueda T Kaku Igaku; 1985 Oct; 22(10):1485-93. PubMed ID: 3879301 [No Abstract] [Full Text] [Related]
8. [Cerebral perfusion studies with N-isopropyl-p-(125I) iodo-amphetamine and SPECT in cerebrovascular disorders]. Kawamura M; Murase K; Nagao S; Watanabe Y; Itoh H; Iio A; Hamamoto K Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Jan; 46(1):38-48. PubMed ID: 3486403 [No Abstract] [Full Text] [Related]
9. [Regional cerebral blood flow in various pediatric neurological patients using 123I-IMP SPECT]. Konishi T; Naganuma Y; Hongou K; Murakami M; Yamatani M; Okada T No To Hattatsu; 1988 May; 20(3):205-10. PubMed ID: 3260513 [No Abstract] [Full Text] [Related]
10. [123I-IMP SPECT in ischemic cerebrovascular disorders--evaluation of delayed image]. Murata J; Kaneko S; Imai T Kaku Igaku; 1988 Feb; 25(2):117-24. PubMed ID: 3260301 [No Abstract] [Full Text] [Related]
11. 123I-Amphetamine single photon emission computed (SPECT) tomography versus 133Xe dynamic SPECT: preliminary results. Buell U; Olteanu-Nerbe V; Kirsch CM; Schmiedek P Nucl Med Commun; 1984 Jul; 5(7):439-49. PubMed ID: 6335743 [No Abstract] [Full Text] [Related]
12. Semiquantifying regional cerebral blood flow by 123I-amphetamine (IMP) SPECT in cerebrovascular disorders: correlations with CBF indices by 133Xe inhalation method. Tsuda Y; Hartmann A; Biersack HJ; Valerius E; Broich K; Reichmann K Eur J Nucl Med; 1988; 14(11):546-51. PubMed ID: 3264788 [TBL] [Abstract][Full Text] [Related]
13. A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease. Ell PJ; Hocknell JM; Jarritt PH; Cullum I; Lui D; Campos-Costa D; Nowotnik DP; Pickett RD; Canning LR; Neirinckx RD Nucl Med Commun; 1985 Aug; 6(8):437-41. PubMed ID: 3877889 [TBL] [Abstract][Full Text] [Related]
14. Cerebral blood-flow tomography: xenon-133 compared with isopropyl-amphetamine-iodine-123: concise communication. Lassen NA; Henriksen L; Holm S; Barry DI; Paulson OB; Vorstrup S; Rapin J; le Poncin-Lafitte M; Moretti JL; Askienazy S; Raynaud C J Nucl Med; 1983 Jan; 24(1):17-21. PubMed ID: 6600275 [TBL] [Abstract][Full Text] [Related]
15. [Local cerebral blood flow measurement using 123I-IMP SPECT in patients with cerebrovascular diseases]. Ueda T; Kinoshita K; Watanabe K; Hoshi H; Jinnouchi S Neurol Med Chir (Tokyo); 1987 May; 27(5):415-21. PubMed ID: 2446180 [No Abstract] [Full Text] [Related]